Impact of metabolic syndrome on elevated serum alanine aminotransferase levels in the Japanese population

Metabolism: Clinical and Experimental

Volumn 58, Issue 8, 2009, Pages 1067-1075

  Saito, Takafumi ^a   Nishise, Yuko ^a   Makino, Naohiko ^a   Haga, Hiroaki ^a   Ishii, Rika ^a   Okumoto, Kazuo ^a   Ito, Jun itsu ^a   Watanabe, Hisayoshi ^a   Saito, Koji ^a   Takeda, Hiroaki ^a   Togashi, Hitoshi ^b   Kubota, Isao ^a   Daimon, Makoto ^a   Kato, Takeo ^a   Kawata, Sumio ^a  

^a YAMAGATA UNIVERSITY   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BODY MASS; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; FEMALE; GLUCOSE HOMEOSTASIS; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INSULIN RESISTANCE; JAPANESE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; ALANINE TRANSAMINASE; ANALYSIS OF VARIANCE; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS B; HEPATITIS C; HUMANS; INSULIN RESISTANCE; JAPAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 67651114146     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.03.008     Document Type: Article

References (38)

1. Matsuzawa Y. The metabolic syndrome and adipocytokines. FEBS Lett 580 (2006) 2917-2921
2. Kawata S. Association of digestive organ disease with metabolic syndrome: role of adipocytokine and its molecular mechanisms. Clin J Gastroenterol 1 (2008) 1-6
3. Russo A., Autelitano M., and Bisati L. Metabolic syndrome and cancer risk. Eur J Cancer 44 (2008) 293-297
4. Bedogni G., Miglioli L., Masutti F., et al. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 42 (2005) 44-52
5. Bellentani S., Tiribelli C., Saccoccio G., et al. Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos study. Hepatology 20 (1994) 1442-1449
6. Liu C.M., Tung T.H., Liu J.H., et al. A community-based epidemiological study of elevated serum alanine aminotransferase levels in Kinmen, Taiwan. World J Gastroenterol 11 (2005) 1616-1622
7. Liangpunsakui S., and Chalasani N. Unexplained elevations in alanine aminotransferase in individuals with the metabolic syndrome: results from the third National Health and Nutrition Survey (NHANES III). Am J Med Sci 329 (2005) 111-116
8. Ioannou G.N., Boyko E.J., and Lee S.P. The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999-2002. Am J Gastroenterol 101 (2006) 76-82
9. Vozarova B., Stefan N., Lindsay R.S., et al. High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 51 (2002) 1889-1895
10. Schindhelm R.K., Dekker J.M., Nijpels G., et al. Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study. Atherosclerosis 191 (2007) 391-396
11. Hanley A.J.G., Williams K., Festa A., et al. Liver markers and development of the metabolic syndrome. The insulin resistance atherosclerosis study. Diabetes 54 (2005) 3140-3147
12. Schindhelm R.K., Dekker J.M., Nijpels G., et al. Alanine aminotransferase and the 6-year risk of the metabolic syndrome in Caucasian men and women: the Hoorn Study. Diabet Med 24 (2007) 430-435
13. Hoon Lee T., Ray Kim W., Benson J.T., et al. Serum aminotransferase activity and mortality risk in a United States community. Hepatology 47 (2008) 880-887
14. Ray Kim W., Flamm S.L., Di Bisceglie A.M., et al. Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease. Hepatology 47 (2008) 1363-1370
15. Park Y.W., Allison D.B., Heymsfield S.B., et al. Larger amounts of visceral adipose tissue in Asian Americans. Obes Res 9 (2001) 381-387
16. Bonora E., Targher G., Alberiche M., et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 23 (2000) 57-63
17. Romero-Gomez M., Del Mar Viloria M., Andrade R.J., et al. Insulin resistance impairs sustained rate to peginterferon plus ribavirin in chronic hepatitis C patients. Gastroenterology 128 (2005) 636-641
18. Grundy S.M., Cleeman J.I., Daniels S.R., et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 112 (2005) 2735-2752
19. Arai H., Yamamoto A., Matsuzawa Y., et al. Prevalence of metabolic syndrome in the general Japanese population in 2000. J Atheroscler Thromb 13 (2006) 202-208
20. van der Poorten D., Kenny D.T., Butler T., et al. Liver disease in adolescents: a cohort study of high-risk individuals. Hepatology 46 (2007) 1750-1758
21. Prati D., Taioli E., Zanella A., et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 137 (2002) 1-10
22. Tanaka J., Kumagai J., Katayama K., et al. Sex- and age-specific carriers of hepatitis B and C viruses in Japan estimated by the prevalence in the 3,485,648 first-time blood donors during 1995-2000. Intervirology 47 (2004) 32-40
23. Elinav E., Ben-Dov I.Z., Ackerman E., et al. Correlation between serum alanine aminotransferase activity and age: an inverted U curve pattern. Am J Gastroenterol 100 (2005) 2201-2204
24. Kariv R., Leshno M., Beth-Or A., et al. Re-evaluation of serum alanine aminotransferase upper normal limit and its modulating factors in a large-scale population study. Liver Int 26 (2006) 445-450
25. Nakanishi N., Suzuki K., and Tatara K. Serum gamma-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men. Diabetes Care 27 (2004) 1427-1437
26. Bo S., Gambino R., Durazzo M., et al. Association between gamma-glutamyl transferase, metabolic abnormalities and inflammation in healthy subjects from a population-based cohort: a possible implication for oxidative stress. World J Gastroenterol 11 (2005) 7109-7117
27. Yamada J., Tomiyama H., Yambe M., et al. Elevated serum levels of alanine aminotransferase and gamma glutamyltransferase are markers of inflammation and oxidative stress independent of the metabolic syndrome. Atherosclerosis 189 (2006) 198-205
28. Oh S.Y., Cho Y.K., Kang M.S., et al. The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic liver diseases. Metabolism 55 (2006) 1604-1609
29. Suzuki A., Angulo P., Lymp J., et al. Chronological development of elevated aminotransferase in a nonalcoholic population. Hepatology 41 (2005) 64-71
30. Fan J.G., Li F., Cai X.B., et al. Effects of nonalcoholic fatty liver disease on the development of metabolic disorders. J Gastroenterol Hepatol 22 (2007) 1086-1091
31. Ioannou G.N., Weiss N.S., Boyko E.J., et al. Contribution of metabolic factors to alanine aminotransferase activity in persons with other causes of liver diseases. Gastroenterology, 128 (2005) 627-635
32. Marrero J.A., Fontana R.J., Su G.L., et al. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology 36 (2002) 1349-1354
33. Bugianesi E., Leone N., Vanni E., et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 123 (2002) 134-140
34. Adams L.A., Lymp J.F., St Sauver J., et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 129 (2005) 113-121
35. Hanley A.J., Wagenknecht L.E., Festa A., et al. Alanine aminotransferase and directly measured insulin sensitivity in a multiethnic cohort: the insulin resistance atherosclerosis study. Diabetes Care 30 (2007) 1819-1827
36. Saiazar M.R., Carbajal H.A., Curciarello J.O., et al. Alanine-aminotransferase: an early marker for insulin resistance?. Medicine (B Aires) 67 (2007) 125-130
37. Kain K., Carter A.M., Grant P.J., et al. Alanine aminotransferase is associated with atherothrombotic risk factors in a British South Asian population. J Thromb Haemost 6 (2008) 737-741
38. Norman D., Bardwell W.A., Arosemena F., et al. Serum aminotransferase levels are associated with markers of hypoxia in patients with obstructive sleep apnea. Sleep 31 (2008) 121-126